Co-treatment with Cur and EGCG, two natural agents, noticeably impedes the expression of cyclin D1 and cyclin B1, inducing NSCLC arrest at the G1 and S/G2 phases and preventing weight loss caused by tumor burden in nude mice with lung tumor xenografts [96]. This evidence concerns the gene CCND1 and non-small cell lung carcinoma.